House Subcommittee Hears Testimony on Legislation to Amend the Controlled Substances Act

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Legislation

House Subcommittee Hears Testimony on Legislation to Amend the Controlled Substances Act

Lily McManus

January 29, 2015 at 07:38:00 ET

Update: The bill number for the Improving Regulatory Transparency for New Medical Therapies Act is now H.R. 639. A bill considered by a House subcommittee would impose new deadlines on the Drug Enforcement Administration in scheduling controlled substances. The Improving Regulatory Transparency for New Medical Therapies Act (H.R. 4299) would amend the Controlled Substances Act (C... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

House Subcommittee Hears Testimony on Legislation to Amend the Controlled Substances Act

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT